Security Reports > Incyte
Incyte
Data Breaches, Cyber Attacks and Security Report
https://incyte.com ᛫ Biotech & Pharmaceuticals
Last updated September 25, 2020
https://incyte.com ᛫ Biotech & Pharmaceuticals
Last updated September 25, 2020
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Incyte is implementing good security practices.
Incyte, Corp is an American pharmaceutical company based in Alapocas, Delaware. The company was founded in Palo Alto, California in 1991 and went public in 1993.Incyte has one drug, Jakafi, which has been approved by the U.S. Food and Drug Administration (FDA) and has been prescribed to several thousands of patients in the United States.As of 2014 the company was developing baricitinib, an oral JAK1 and JAK2 inhibitor drug for rheumatoid arthritis in partnership with Eli Lilly. It gained EU approval in February 2017.
This report shows a preliminary security rating for Incyte. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.
Get a deeper scan →Read more about the latest issues in cybersecurity
Compare Incyte's security performance with other companies